Loxo@Lilly Oncology Medical
@LoxoLillyOnc
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK
29-03-2022 16:43:22
85 Tweets
4,6K Followers
646 Following
At #ESMO22 – SWOG Cancer Research Network is presenting exploratory analysis from Lung-MAP S1800A, a study investigating OS w/ a VEGFR2 inhibitor + a PD1 inhibitor in pts w/ advanced #NSCLC following progression on prior ICI & platinum chemotherapy. #LCSM
View presentation: e.lilly/3DcaGWw